"Xingguang Yiyi-In-Depth Interpretation" Season 2 Online Conference

In recent years, the development of CAR-T cell therapy has expanded from leukemia to lymphoma and myeloma.
China is a major country in CAR-T therapy and has now become the country that has carried out the most clinical trials of CAR-T therapy.
However, the domestic approved CAR -T cell drugs are in a blank period for a long time
.

Cancer Center of Sun Yat-sen Huang Huiqiang Jiaoshou , Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Hu Yu Jiaoshou presidency;

Second Affiliated Hospital of Zhejiang University School of Medicine, Qian Wen Bin , Professor , Cancer Hospital of Guangxi Medical Cen Hong Professor , Guangdong Provincial People's Hospital Li Wenyu professor chaired;

Cancer Hospital of Sun Yat-sen Xiayi Professor , First Affiliated Hospital of Zhejiang University Yuwen Juan professor and Huazhong University of Science and Technology, Union Hospital, Mei Heng Professor depth interpretation of real-world data and research focus;

At the same time , Professor Wu Yong from the Union Hospital of Fujian Medical University, Professor Zhao Ying from the First People's Hospital of Foshan City, Professor Shi Xue from the Qingdao University Affiliated Hospital , Professor Li Huijun from the Shenzhen Hospital of the University of Hong Kong , and Zhang Zhongming from the First Affiliated Hospital of Guangxi Medical University were invited .
Professor, first Affiliated hospital of Zhejiang University Hu Yong Xian professor , was the Discussant .

Experts attending the conference have a strong lineup and are full of dry goods.

You can click the following link or scan the QR code in the poster to watch the live broadcast online:

https://webcast.